rs764196171
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PP4PM2_SupportingPM3
This summary comes from the ClinGen Evidence Repository: The NM_000203.5:c.1029C>A (p.Tyr343Ter) variant in IDUA is a nonsense variant predicted to cause a premature stop codon in biologically-relevant exon 8 out of 14, leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). At least 1 patient with this variant had documented IDUA deficiency within the affected range in leukocytes and urinary GAGs expressed as heparan and dermatan sulfate GAG elevation above normal range (PP4; PMID:35141277). This variant has been detected in at least 2 individuals with MPS I. Of those individuals, both were compound heterozygous for the variant and a pathogenic variant (c.208C>T p (Gln70Ter)) and neither of those were confirmed in trans (PM3; PMID:35141277). This variant is absent in gnomAD v4.1.0. (PM2_Supporting). To our knowledge, the results of functional assays have not been reported for this variant. In summary, this variant meets the criteria to be classified as pathogenic for MPS I based on the IDUA-specific ACMG/AMP criteria applied, as specified by the ClinGen Lysosomal Diseases Variant Curation Expert panel (Specifications Version 1.0): PVS1, PP4, PM3, PM2_Supporting. (Classification approved by the ClinGen Lysosomal Diseases Variant Curation Expert Panel on December 5, 2024) LINK:https://erepo.genome.network/evrepo/ui/classification/CA356984/MONDO:0001586/091
Frequency
Consequence
NM_000203.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IDUA | ENST00000514224.2 | c.1029C>A | p.Tyr343* | stop_gained | Exon 8 of 14 | 2 | NM_000203.5 | ENSP00000425081.2 | ||
IDUA | ENST00000247933.9 | c.1029C>A | p.Tyr343* | stop_gained | Exon 8 of 14 | 1 | ENSP00000247933.4 | |||
IDUA | ENST00000514698.5 | n.1136C>A | non_coding_transcript_exon_variant | Exon 5 of 11 | 5 | |||||
IDUA | ENST00000652070.1 | n.1085C>A | non_coding_transcript_exon_variant | Exon 7 of 13 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome Cov.: 35
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
Mucopolysaccharidosis type 1 Pathogenic:1Other:1
Variant causes attenuated MPS I; premature stop codon used as an acceptor splice site, generating an in-frame deletion -
The NM_000203.5:c.1029C>A (p.Tyr343Ter) variant in IDUA is a nonsense variant predicted to cause a premature stop codon in biologically-relevant exon 8 out of 14, leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). At least 1 patient with this variant had documented IDUA deficiency within the affected range in leukocytes and urinary GAGs expressed as heparan and dermatan sulfate GAG elevation above normal range (PP4; PMID: 35141277). This variant has been detected in at least 2 individuals with MPS I. Of those individuals, both were compound heterozygous for the variant and a pathogenic variant (c.208C>T p (Gln70Ter)) and neither of those were confirmed in trans (PM3; PMID: 35141277). This variant is absent in gnomAD v4.1.0. (PM2_Supporting). To our knowledge, the results of functional assays have not been reported for this variant. In summary, this variant meets the criteria to be classified as pathogenic for MPS I based on the IDUA-specific ACMG/AMP criteria applied, as specified by the ClinGen Lysosomal Diseases Variant Curation Expert panel (Specifications Version 1.0): PVS1, PP4, PM3, PM2_Supporting. (Classification approved by the ClinGen Lysosomal Diseases Variant Curation Expert Panel on December 5, 2024) -
Hurler syndrome Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at